English
Spanish
French
Italian
German
NEWS
Latest News
Recognizing HS: From First Signs to an Accurate Diagnosis
October 16, 2025
Hidradenitis suppurativa is often misunderstood and underdiagnosed—even though its telltale signs can emerge early. Explore how key symptoms like painful nodules, abscesses, and draining tunnels can offer a pathway to timely diagnosis and more compassionate, effective care.
Read more
Beyond the Surface: October 2025
October 10, 2025
This month’s newsletter features exciting updates on the new HS Buddy Program, details for SHSA 2025 in Nashville, current grant opportunities, and the latest HS in the News. Don’t miss what’s happening in the HS community — check it out now!
Read more
Can Quitting Smoking Lower the Risk of Hidradenitis Suppurativa?
September 29, 2025
A new study of more than 6 million people shows that quitting smoking can cut the risk of hidradenitis suppurativa by about one-third—but the benefits appear only after staying smoke-free for at least three years. Relapsing, however, brings the risk right back up.
Read more
HS Summit Spotlights Gaps in Diagnosis and Care
September 11, 2025
The summit highlighted the challenges of diagnosing HS, emphasizing the need for awareness & recognizing chronic, recurrent patterns. Patient storytelling & joint panels underscored the real-world burden of HS & the importance of early intervention. Collaboration between patients & providers is crucial for improving outcomes & raising the standard of care in HS management.
Read more
HS Foundation Launches New HS Buddy Program to Support Clinical Trial Participants
July 29, 2025
The HS Buddy Program is a peer support initiative designed to connect individuals currently in or considering a clinical trial with experienced "buddies" who can offer guidance, share personal insights, and help navigate the clinical trial journey. Learn how you can get involved as a participant or a peer mentor.
Read more
From the Heart: July 2025
July 17, 2025
In this issue: We're celebrating 20 years of advancing care, research, and support for those impacted by Hidradenitis Suppurativa. Catch up on recent news in the HS world, important updates for SHSA 2024 (including early bird deadlines), new research opportunities, and ways to get involved in our growing community.
Read more
New Study Explores Tunnel-Targeted Antimicrobial Gel for HS Treatment
July 11, 2025
A newly published prospective study in JAAD highlights a novel approach for treating Hidradenitis Suppurativa using a topical clindamycin gel delivered directly into tunnels. The treatment showed promising results in reducing inflammation, resolving tunnels, restoring microbial balance, and improving quality of life. Led by researchers at the University of Miami, including HSF President Dr. Hadar Lev-Tov, this work offers new insights into localized therapies for HS.
Read more
Dermatologic Procedures for Hidradenitis Suppurativa
July 10, 2025
Explore how dermatologic procedures like deroofing, excision, and laser therapies are helping patients with hidradenitis suppurativa achieve better outcomes. This article highlights expert insights on selecting the right approach based on severity, recurrence, and patient goals.
Read more
Efficacy and Safety of Medical Interventions for Moderate to Severe Hidradenitis Suppurativa
July 2, 2025
A newly published living systematic review and network meta-analysis in JAMA Dermatology offers an in-depth look at the current evidence on medical therapies for HS. This important research helps inform treatment decisions and highlights the growing momentum in HS clinical trials.
Read more
Best practice in the management of Hidradenitis Suppurativa lesions
July 1, 2025
Access the Best Practice in the Management of Hidradenitis Suppurativa Lesions—an international consensus document offering practical, evidence-informed guidance on diagnosing, assessing & managing HS lesions. Developed by a panel of wound care & dermatology experts, this resource covers cleansing, dressing selection, pain control, surgical options & more.
Read more